REFERENCES
- Accili, D., Drago, J., Lee, E. J., Johnson, M. D., Cool, M. H., Salvatore, P., Asico, L. D., Jose, P. A., Taylor, S. I., and Westphal, H.. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106–109
- Ando, A., Momomura, K., Tobe, K., Yamamoto-Honda, R., Sakura, H., Tamori, Y., Kaburagi, Y., Koshio, O., Akanuma, Y., Yazaki, Y. et al. 1992. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine. J. Biol. Chem. 267:12788–12796
- Araki, E., Lipes, M. A., Patti, M. E., Bruning, J. C., Haag, B. R., Johnson, R. S., and Kahn, C. R.. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190
- Backer, J. M., Schroeder, G. G., Kahn, C. R., Myers, M. J., Wilden, P. A., Cahill, D. A., and White, M. F.. 1992. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J. Biol. Chem. 267:1367–1374
- Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A.. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82
- Beauchemin, N. et al. 1999. Nomenclature announcement. Exp. Cell Res. 252:243–249
- Blenis, J.. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889–5892
- Cheung, P. H., Thompson, N. L., Earley, K., Culic, O., Hixson, D., and Lin, S. H.. 1993. Cell-CAM105 isoforms with different adhesion functions are coexpressed in adult rat tissues and during liver development. J. Biol. Chem. 268:6139–6146
- Craparo, A., O'Neill, T. J., and Gustafson, T. A.. 1995. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. J. Biol. Chem. 270:15639–15643
- Crews, C. M., and Erikson, R. L.. 1993. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74:215–217
- Danielsen, A. G., Liu, F., Hosomi, Y., Shii, K., and Roth, R. A.. 1995. Activation of protein kinase C alpha inhibits signaling by members of the insulin receptor family. J. Biol. Chem. 270:21600–21605
- Di Cola, G., Cool, M. H., and Accili, D.. 1997. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J. Clin. Investig. 99:2538–2544
- Edlund, M., and Öbrink, B.. 1993. Evidence for calmodulin binding to the cytoplasmic domains of two C-CAM isoforms. FEBS Lett. 327:90–94
- Esposito, D. L., Blakesley, V. A., Koval, A. P., Scrimgeour, A. G., and LeRoith, D.. 1997. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals. Endocrinology 138:2979–2988
- Faria, T. N., Blakesley, V. A., Kato, H., Stannard, B., LeRoith, D., Roberts, C. T.Jr.. 1994. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J. Biol. Chem. 269:13922–13928
- Formisano, P., Najjar, S. M., Gross, C. N., Philippe, N., Oriente, F., Kern-Buell, C. I., Accili, D., and Gorden, P.. 1995. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J. Biol. Chem. 270:24073–24077
- Gale, N. W., Kaplan, S., Lowenstein, E. J., Schlessinger, J., and Bar-Sagi, D.. 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363:88–92
- Grønborg, M., Wulff, B. S., Rasmussen, J. S., Kjeldsen, T., and Gammeltoft, S.. 1993. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase. J. Biol. Chem. 268:23435–23440
- Gustafson, T. A., He, W., Craparo, A., Schaub, C. D., and O'Neill, T. J.. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:2500–2508
- Hixson, D. C., McEntire, K. D., and Obrink, B.. 1985. Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. Cancer Res. 45:3742–3749
- Hsieh, J.-T., Luo, W., Song, W., Wang, Y., Kleinerman, D. I., Van, N. T., and Lin, S.-H.. 1995. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 55:190–197
- Huber, M., Izzi, L., Grondin, P., Houde, C., Kunath, T., Veillette, A., and Beauchemin, N.. 1999. The carboxy-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J. Biol. Chem. 274:335–344
- Kaburagi, Y., Momomura, K., Yamamoto, H. R., Tobe, K., Tamori, Y., Sakura, H., Akanuma, Y., Yazaki, Y., and Kadowaki, T.. 1993. Site-directed mutagenesis of the juxtamembrane domain of the human insulin receptor. J. Biol. Chem. 268:16610–16622
- Kato, H., Faria, T. N., Stannard, B., Roberts, C. T.Jr., and LeRoith, D.. 1994. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol. Endocrinol. 8:40–50
- Kimura, M., and Ogihara, M.. 1997. Proliferation of adult rat hepatocytes in primary culture induced by insulin is potentiated by cAMP-elevating agents. Eur. J. Pharmacol. 327:87–95
- Kleinerman, D. I., Dinney, C. P., Zhang, W. W., Lin, S. H., Van, N. T., and Hsieh, J. T.. 1996. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Cancer Res. 56:3431–3425
- Kleinerman, D. I., Troncoso, P., Lin, S. H., Pisters, L. L., Sherwood, E. R., Brooks, T., von Eschenbach, A. C., and Hsieh, J. T.. 1995. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res. 55:1215–1220
- Lee, J., and Pilch, P. F.. 1994. The insulin receptor: structure, function and signalling. Am. J. Physiol. 266:C319–C334
- Levy-Toledano, R., Caro, L. H., Accili, D., and Taylor, S. I.. 1994. Investigation of the mechanism of the dominant negative effect of mutations in the tyrosine kinase domain of the insulin receptor. EMBO J. 13:835–842
- Li, S., Resnicoff, M., and Baserga, R.. 1996. Effect of mutations at serines 1280–1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271:12254–12260
- Lin, S. H., and Guidotti, G.. 1989. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. The primary structure of the ecto-ATPase is similar to that of the human biliary glycoprotein I. J. Biol. Chem. 264:14408–14414
- Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A.. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72
- Lowenstein, E. J., Daly, R. J., Batzer, A. G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Skolnik, E. Y., Bar-Sagi, D., and Schlessinger, J.. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431–442
- Luo, W., Earley, K., Tantingco, V., Hixson, D. C., Liang, T. C., and Lin, S. H.. 1998. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition. Oncogene 16:1141–1147
- Luo, W., Wood, C. G., Earley, K., Hung, M. C., and Lin, S. H.. 1997. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Oncogene 14:1697–1704
- Maegawa, H., McClain, D. A., Freidenberg, G., Olefsky, J. M., Napier, M., Lipari, T., Dull, T. J., Lee, J., and Ullrich, A.. 1988. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects. J. Biol. Chem. 263:8912–8917
- Margolis, R. N., Schell, M. J., Taylor, S. I., and Hubbard, A. L.. 1990. Hepatocyte plasma membrane ecto-ATPase (pp120/HA4) is a substrate for tyrosine kinase activity of the insulin receptor. Biochem. Biophys. Res. Commun. 166:562–566
- Morgan, D., Jarnagin, K., and Roth, R.. 1986. Purification and characterization of the receptor for insulin-like growth factor 1. Biochemistry 25:5560–5564
- Murakami, M. S., and Rosen, O. M.. 1991. The role of insulin receptor autophosphorylation in signal transduction. J. Biol. Chem. 266:22653–22660
- Najjar, S. M.. 1998. pp120, a substrate of the insulin receptor tyrosine kinase, is associated with phosphatase activity. Biochem. Biophys. Res. Commun. 247:457–461
- Najjar, S. M., Accili, D., Philippe, N., Jernberg, J., Margolis, R., and Taylor, S. I.. 1993. pp120/ecto-ATPase, an endogenous substrate of the insulin receptor tyrosine kinase, is expressed as two variably spliced isoforms. J. Biol. Chem. 268:1201–1206
- Najjar, S. M., Blakesley, V. A., Li Calzi, S., Kato, H., LeRoith, D., and Choice, C. V.. 1997. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Biochemistry 36:6827–6834
- Najjar, S. M., Choice, C. V., Soni, P., Whitman, C. M., and Poy, M. N.. 1998. Effect of pp120 on receptor-mediated insulin endocytosis is regulated by the juxtamembrane domain of the insulin receptor. J. Biol. Chem. 273:12923–12928
- Najjar, S. M., and Lewis, R. E.. 1999. Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 230:41–45
- Najjar, S. M., Philippe, N., Suzuki, Y., Ignacio, G. A., Formisano, P., Accili, D., and Taylor, S. I.. 1995. Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry 34:9341–9349
- Nédellec, P., Dveksler, G. S., Daniels, E., Turbide, C., Chow, B., Basile, A. A., Holmes, K. V., and Beauchemin, N.. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525–4537
- Neumaier, M., Paululat, S., Chan, A., Matthaes, P., and Wagener, C.. 1993. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA 90:10744–10748
- Pang, L., Milarski, K. L., Ohmichi, M., Takata, Y., Olefsky, J. M., and Saltiel, A. R.. 1994. Mutation of two carboxyl-terminal tyrosines in the insulin receptor results in enhanced activation of mitogen-activated protein kinase. J. Biol. Chem. 269:10604–10608
- Pillay, T. S., Whittaker, J., Lammers, R., Ullrich, A., and Siddle, K.. 1991. Multisite serine phosphorylation of the insulin and IGF-I receptors in transfected cells. FEBS Lett. 288:206–211
- Pronk, G. J., McGlade, J., Pelicci, G., Pawson, T., and Bos, J. I.. 1993. Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J. Biol. Chem. 268:5748–5753
- Reusch, J. E., Hsieh, P., Bhuripanyo, P., Carel, K., Leitner, J. W., Olefsky, J. M., and Draznin, B.. 1995. Insulin inhibits nuclear phosphatase activity: requirement for the C-terminal domain of the insulin receptor. Endocrinology 136:2464–2469
- Rosenberg, M., Nedellec, P., Jothy, S., Fleiszer, D., Turbide, C., and Beauchemin, N.. 1993. The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues. Cancer Res. 53:4938–4945
- Rother, K. I., Imai, Y., Caruso, M., Beguinot, F., Formisano, P., and Accili, D.. 1998. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273:17491–17497
- Sasaoka, T., Rose, D. W., Saltiel, A. R., Draznin, B., and Olefsky, J. M.. 1994. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-I, and epidermal growth factor. J. Biol. Chem. 269:13689–13694
- Shier, P., and Watt, V. M.. 1992. Tissue-specific expression of the rat insulin receptor-related receptor gene. Mol. Endocrinol. 6:723–729
- Sippel, C. J., Fallon, R. J., and Perlmutter, D. H.. 1994. Bile acid efflux mediated by the rat liver canalicular bile acid transport/ecto-ATPase protein requires serine 503 phosphorylation and is regulated by tyrosine 488 phosphorylation. J. Biol. Chem. 269:19539–19545
- Skolnik, E. Y., Batzer, A., Li, N., Lee, C. H., Lowenstein, E., Mohammadi, M., Margolis, B., and Schlessinger, J.. 1993. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953–1955
- Staubs, P. A., Reichart, D. R., Saltiel, A. R., Milarski, K. L., Maegawa, H., Berhanu, P., Olefsky, J. M., and Seely, B. L.. 1994. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. J. Biol. Chem. 269:27186–27192
- Takata, Y., Webster, N. J., and Olefsky, J. M.. 1991. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signaling but enhanced mitogenic signaling properties. J. Biol. Chem. 266:9135–9139
- Takata, Y., Webster, N. J. G., and Olefsky, J. M.. 1992. Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites. J. Biol. Chem. 267:9065–9070
- Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S. et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182–186
- Tartare, S., Mothe, I., Kowalski-Chauvel, A., Breittmayer, J. P., Ballotti, R., and Van Obberghen, E.. 1994. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor. J. Biol. Chem. 269:11449–11455
- Thompson, N. L., Lin, S. H., Panzica, M. A., and Hixson, D. C.. 1994. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology 62:209–220
- Turbide, C., Kunath, T., Daniels, E., and Beauchemin, N.. 1997. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res. 57:2781–2788
- Van Horn, D. J., Myers, M. G.Jr., and Backer, J. M.. 1994. Direct activation of the phosphatidylinositol 3-kinase by the insulin receptor. J. Biol. Chem. 269:29–32
- White, M. F.. 1998. The IRS-signalling system: a network of docking proteins that mediate insulin and interleukin signalling. Mol. Cell. Biochem. 182:3–11
- White, M. F., and Kahn, C. R.. 1994. The insulin signaling system. J. Biol. Chem. 269:1–4
- White, M. F., Livingston, J. N., Backer, J. M., Lauris, V., Dull, T. J., Ullrich, A., and Kahn, C. R.. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54:641–649
- Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J. M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., Bonner-Weir, S., and White, M. F.. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904
- Xiao, S., Rose, D. W., Sasaoka, T., Maegawa, H., Burke, T. R. J., Roller, P. P., Shoelson, S. E., and Olefsky, J. M.. 1994. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269:21244–21248
- Yamamoto-Honda, R., Kadowaki, T., Momomura, K., Tobe, K., Tamori, Y., Shibasaki, Y., Mori, Y., Kaburagi, Y., Koshio, O., Akanuma, Y. et al. 1993. Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin. J. Biol. Chem. 268:16859–16865
- Yamasaki, H., Prager, D., Gebremedhin, S., and Melmed, S.. 1992. Human insulin-like growth factor I receptor 950 tyrosine is required for somatotroph growth factor signal transduction. J. Biol. Chem. 267:20953–20958
- Zhang, B., and Roth, R. A.. 1992. The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. J. Biol. Chem. 267:18320–18328